MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice
MicroRNA-29 (miR-29) has been shown to play a critical role in reducing inflammation and fibrosis following liver injury. Non-alcoholic fatty liver disease (NAFLD) occurs when fat is deposited (steatosis) in the liver due to causes other than excessive alcohol use and is associated with liver fibros...
Main Authors: | Hung-Yu Lin, Feng-Sheng Wang, Ya-Ling Yang, Ying-Hsien Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1298 |
Similar Items
-
The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
by: Hung-Yu Lin, et al.
Published: (2020-04-01) -
MicroRNA mimicry blocks pulmonary fibrosis
by: Rusty L Montgomery, et al.
Published: (2014-09-01) -
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01) -
MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis
by: Saeideh Jafarinejad-Farsangi, et al.
Published: (2019-04-01) -
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
by: Maurizio Chioccioli, et al.
Published: (2022-11-01)